Korean J Urol.  2007 Oct;48(10):1075-1081. 10.4111/kju.2007.48.10.1075.

The Effect of Anticholinergic Drug Treatment before a Midurethral Sling Operation in Mixed Urinary Incontinence

• Oh BS
• Park SH
• Park SS

• KMID: 2139742
• DOI: http://doi.org/10.4111/kju.2007.48.10.1075

Abstract

PURPOSE: We investigated the effect of anticholinergic drug treatment before midurethral sling surgery in patients with mixed urinary incontinence(MUI).
MATERIALS AND METHODS
Between January 2004 and December 2006, 112 female patients with MUI were evaluated. Forty-seven patients were not medicated with anticholinergic drugs(Group A) and 65 patients were medicated with anticholinergic drugs(Group B) for 2 weeks or more(2-8 weeks, mean 2.34+/-1.02) before the midurethral sling operation. After the midurethral sling operation, the patients were followed up for 4 weeks or more(4-48 weeks, Group A is 7.83+/-8.70, Group B is 6.77+/-7.58). Cure of the incontinence after the procedure was defined as the absence of subjective symptoms such as frequency, urgency, urge incontinence and the absence of objective leakage on stress testing. All other cases were considered failures.
RESULTS
There were no significant differences between the group that was not medicated preoperatively (Group A) and the group that was preoperatively medicated(Group B)(cure rate of Group A was 87.2% and Group B was 89.2%, p=0.745) in the cure rate for pure stress urinary incontinence. However, comparison of the postoperative results for the MUI showed significant differences (cure rate of Group A was 63.8% and Group B was 81.6%, p=0.035). The cure rate was significantly higher in the preoperatively medicated patients than in the patients who were not preoperatively medicated with regard to the MUI.
CONCLUSIONS
Our findings suggest that treatment with anticholinergic medications before a midurethral sling operation improves the cure rate in patients with MUI.

Keyword

Urinary incontinence; Treatment

MeSH Terms

Exercise Test
Female
Humans
Suburethral Slings*
Urinary Incontinence*
Urinary Incontinence, Urge

Reference

1. Klutke C, Siegel S, Carlin B, Paszkiewicz E, Kirkemo A, Klutke J. Urinary retention after tension-free vaginal tape procedure: incidenece and treatment. Urology. 2001. 58:697–701.

2. Klutke CG, Little NA, Raz S. The anatomy of stress incontinence. AUA Update Series. 1990. 9:306–311.

3. Ulmsten U, Johnson P, Rezapour M. A three-year follow up of tension free vaginal tape for surgical treatment of female stress urinary incontinence. Br J Obstet Gynaecol. 1999. 106:345–350.

4. Wang AC, Lo TS. Tension-free vaginal tape. A minimally invasive solution to stress urinary incontinence in women. J Repord Med. 1998. 43:429–434.

5. Seo JB, Lee JZ. The epidemiologic study of the urinary incontinence in community-dwelling women over 50 years old. Korean J Urol. 1999. 40:1519–1524.

6. Ku JH, Shin JW, Son HC, Oh SJ, Kim SW, Paick JS. Predictive factors for persistent urgency or urge incontinence after tension-free vaginal tape procedure in mixed urinary incontinence. Korean J Urol. 2004. 45:330–336.

7. Merlin T, Arnold E, Petros P, MacTaggart P, Tulloch A, Faulkner K, et al. A systemic review of tension-free urethropexy for stress urinary incontinence: intravaginal slingplasty and the tension-free vaginal tape procedures. BJU Int. 2001. 88:871–880.

8. Rezapour M, Ulmsten U. Tension-free vaginal tape (TVT) in women with mixed urinary incontinence-- a long-term follow-up. Int Urogynecol J Pelvic Floor Dysfunct. 2001. 12:Suppl 2. S15–S18.

9. Paick JS, Ku JH, Kim SW, Oh SJ, Son HC, Shin JW. Tension-free vaginal tape procedure for the treatment of mixed urinary incontinence: significance of maximal urethral closure pressure. J Urol. 2004. 172:1001–1005.

10. Doo CK, Kim JB, Song CR, Kim JH, Choi JB, Lee KS, et al. Changes in overactive bladder symptoms after discontinuation of a successful treatment with antimuscarinic agent: a prospective trial. Korean J Urol. 2005. 46:713–718.

11. Ingelman-Sundberg A, Ulmsten U. Surgical treatment of female urinary stress incontinence. Contrib Gynecol Obstet. 1983. 10:51–69.

12. Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. Continence program for women research group. Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress inventory. Neurourol Urodyn. 1995. 14:131–139.

13. Bang SI, Lee JJ. Outcomes of tension-free vaginal tape according to postoperative period in the treatment of female urinary incontinence. Korean J Urol. 2004. 45:1121–1125.

14. Choo MS. Recent trends in the surgical treatment of female stress urinary incontinence. Korean J Urol. 2004. 45:509–517.

15. Cho DY, Lee JG. The comparison of tension-free vaginal tape procedure in the management of stress urinary incontinence caused by anatomical incontinence and intrinsic sphincter deficiency. Korean J Urol. 2004. 45:903–908.

16. Artibani W. Difficult to manage patient populations-mixed symptomatology. BJU Int. 2000. 85:Suppl 3. 53–54.

17. Chaliha C, Khullar V. Mixed incontinence. Urology. 2004. 63:Suppl 1. 51–57.

18. Khullar V, Digesu A, Chaliha C, Khan M, Huchins A. Mixed incontinence: How should it be treated? Neurourol Urodyn. 2002. 21:Suppl. 378–379. abstract 73.

19. Jeffry L, Deval B, Birsan A, Soriano D, Darai E. Objective and subjective cure rates after tension-free vaginal tape for treatment of urinary incontinence. Urology. 2001. 58:702–706.

20. Duckett JR, Tamilselvi A. Effect of tension-free vaginal tape in women with a urodynamic diagnosis of idiopathic detrusor overactivity and stress incontinence. Br J Obstet Gynecol. 2006. 113:30–33.